Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BMS appoints Christopher Perley as Devens general manager

This article was originally published in Scrip

Executive Summary

Bristol-Myers Squibbhas named Christopher Perley vice-president and general manager of its Devens, Massachusetts biologics manufacturing facility. He will be responsible for continuing the supervision of the project to build the facility and will have overall management responsibility for the site when it becomes operational in 2011. Mr Perley was previously vice-president of network strategy at Wyeth Biotech. He has also held manufacturing and biotechnology process development roles at the Genetics Institute and Roche.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts